Enfuvirtide

FUZEON 90 mg/ml POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE

90 mg polvo y disolvente para solución inyectableSpainAuthorisedAuthorised 4 Jun 2003

In other countries

The same active substances on other registers, the same brand first.

FuzeonBrazil · Produtos Roche Químicos e Farmacêuticos S.A.Same brand
FuzeonCanada · 108 MG / VIAL · Powder For Solution · Hoffmann-LA Roche LimitedSame brand
FuzeonEuropean Union · Roche Registration GmbHSame brand
FuzeonCroatiaSame brand
FuzeonItaly · Polvere e solvente per soluzione iniettabile · Roche Registration GMBHSame brand
Fuzeon 90 mg/ml, poeder en oplosmiddel voor oplossing voor injectieNetherlands · Poeder en oplosmiddel voor oplossing voor injectie · Roche Registration GmbHSame brand
FuzeonUnited States · 90MG/VIAL · injectable · RocheSame brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Enfuvirtide

FUZEON 90 mg/ml POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE

90 mg polvo y disolvente para solución inyectableSpainAuthorisedAuthorised 4 Jun 2003

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Packs

Pack	Code	Status
FUZEON 90 mg/ml POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 60 viales + 60 viales de disolvente	828251

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Enfuvirtide
Strength: 90 mg
Dosage form: polvo y disolvente para solución inyectable
Route: vía subcutánea
Register: Spain (AEMPS)
Status: Authorised
Status in the register: Autorizado, no comercializado
Authorised: 4 Jun 2003
Registration: 03252001
Marketing authorisation holder: Roche Registration Gmbh
Procedure: EU centralised
Supply: Uso Hospitalario